Molecular landmarks along the axonal route: axonal transport in health and disease

Current Opinion in Cell Biology

Volumn 20, Issue 4, 2008, Pages 445-453

  Salinas, Sara ^a   Bilsland, Lynsey G ^a   Schiavo, Giampietro ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; DYNEIN ADENOSINE TRIPHOSPHATASE; HUNTINGTIN; KINESIN; MOLECULAR MOTOR; MYOSIN; NEUROTROPHIN RECEPTOR; TAU PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BULBAR PARALYSIS; CELL ORGANELLE; CYTOSKELETON; FRONTOTEMPORAL DEMENTIA; GALACTOSIALIDOSIS; GENE OVEREXPRESSION; HEREDITARY MOTOR SENSORY NEUROPATHY; HOMEOSTASIS; HUMAN; HUNTINGTON CHOREA; MICROTUBULE; MISSENSE MUTATION; MITOCHONDRION; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NEUROLOGIC DISEASE; NEUROPATHY; NONHUMAN; NONSENSE MUTATION; PARKINSONISM; POINT MUTATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RNA SPLICING; RNA TRANSPORT; SIGNAL TRANSDUCTION; SPINAL MUSCULAR ATROPHY; TAUTOPATHY; TRANSPORT KINETICS;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; AXONAL TRANSPORT; AXONS; HUMANS; MOLECULAR MOTOR PROTEINS; NEURODEGENERATIVE DISEASES; ORGANELLES;

EID: 47149095748     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2008.04.002     Document Type: Review

References (65)

1. Hirokawa N., and Takemura R. Molecular motors and mechanisms of directional transport in neurons. Nat Rev Neurosci 6 (2005) 201-214
2. Vale R.D. The molecular motor toolbox for intracellular transport. Cell 112 (2003) 467-480
3. Duncan J.E., and Goldstein L.S. The genetics of axonal transport and axonal transport disorders. PLoS Genet 2 (2006) e124
4. Zhang F., Strom A.L., Fukada K., Lee S., Hayward L.J., and Zhu H. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J Biol Chem 282 (2007) 16691-16699
5. Magnani E., Fan J., Gasparini L., Golding M., Williams M., Schiavo G., Goedert M., Amos L.A., and Spillantini M.G. Interaction of tau protein with the dynactin complex. EMBO J 26 (2007) 4546-4554
6. Dixit R., Ross J.L., Goldman Y.E., and Holzbaur E.L. Differential regulation of dynein and kinesin motor proteins by tau. Science 319 (2008) 1086-1089. Using in vitro motility assays and GFP-tagged dynein and kinesin, the authors demonstrated that kinesin motor activity was affected at tau concentrations 10-fold lower than dynein, suggesting that kinesin-dependent transport is more sensitive to MT-binding proteins. The accumulation of tau in the soma of neurons in Alzheimer's disease may therefore inhibit kinesin-dependent transport and lead to neurodegeneration.
7. Ibanez C.F. Message in a bottle: long-range retrograde signaling in the nervous system. Trends Cell Biol 17 (2007) 519-528
8. von Zastrow M., and Sorkin A. Signaling on the endocytic pathway. Curr Opin Cell Biol 19 (2007) 436-445
9. Liu J., Lamb D., Chou M.M., Liu Y.J., and Li G. Nerve growth factor-mediated neurite outgrowth via regulation of Rab5. Mol Biol Cell 18 (2007) 1375-1384
10. Saxena S., Bucci C., Weis J., and Kruttgen A. The small GTPase Rab7 controls the endosomal trafficking and neuritogenic signaling of the nerve growth factor receptor TrkA. J Neurosci 25 (2005) 10930-10940
11. Cui B., Wu C., Chen L., Ramirez A., Bearer E.L., Li W.P., Mobley W.C., and Chu S. One at a time, live tracking of NGF axonal transport using quantum dots. Proc Natl Acad Sci U S A 104 (2007) 13666-13671
12. Valdez G., Philippidou P., Rosenbaum J., Akmentin W., Shao Y., and Halegoua S. Trk-signaling endosomes are generated by Rac-dependent macroendocytosis. Proc Natl Acad Sci U S A 104 (2007) 12270-12275
13. Deinhardt K., Salinas S., Verastegui C., Watson R., Worth D., Hanrahan S., Bucci C., and Schiavo G. Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 52 (2006) 293-305. The binding fragment of tetanus toxin coupled to magnetic nanobeads was utilised to isolate axonal retrograde carriers used by this toxin, neurotrophins and their receptors to travel back to the soma in primary motor neurons. This strategy enabled the identification of Rab7 as a key component of these structures. The activity of Rab7 was shown to be essential for axonal retrograde transport.
14. Rink J., Ghigo E., Kalaidzidis Y., and Zerial M. Rab conversion as a mechanism of progression from early to late endosomes. Cell 122 (2005) 735-749
15. Lakadamyali M., Rust M.J., and Zhuang X. Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 124 (2006) 997-1009. This study reported on a new pre-early endosomal sorting mechanism occurring during cargo progression along the endocytic pathway in cultured cells. A dynamic population of Rab5 endosomes was shown to sort selective cargoes, such as LDL and influenza virus, towards late and degradative endosomes whereas transferrin was also delivered to a distinct pool of static early endosomes. Disruption of MT and knockdown of the clathrin adaptor AP2 were shown to impair this pre-early endosome sorting.
16. Driskell O.J., Mironov A., Allan V.J., and Woodman P.G. Dynein is required for receptor sorting and the morphogenesis of early endosomes. Nat Cell Biol 9 (2007) 113-120
17. Johansson M., Rocha N., Zwart W., Jordens I., Janssen L., Kuijl C., Olkkonen V.M., and Neefjes J. Activation of endosomal dynein motors by stepwise assembly of Rab7-RILP-p150Glued, ORP1L, and the receptor betalll spectrin. J Cell Biol 176 (2007) 459-471
18. Yap C.C., Wisco D., Kujala P., Lasiecka Z.M., Cannon J.T., Chang M.C., Hirling H., Klumperman J., and Winckler B. The somatodendritic endosomal regulator NEEP21 facilitates axonal targeting of L1/NgCAM. J Cell Biol 180 (2008) 827-842. This study uncovers the molecular mechanisms controlling the axonal targeting of L1/NgCAM. This adhesion molecule uses a somato-dendritic compartment regulated by the neuronal specific endosomal protein NEEP21 to access the axonal plasma membrane. Live cell experiments showed a preferential axonal anterograde transport of NgCAM-containing small vesicles. NEEP21 knockdown causes missorting of L1/NgCAM to dendrites owing to the impairment of its progression through the early endosomal compartment and axonal recycling.
19. Gitler A.D., Bevis B.J., Shorter J., Strathearn K.E., Hamamichi S., Su L.J., Caldwell K.A., Caldwell G.A., Rochet J.C., McCaffery J.M., et al. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci U S A 105 (2008) 145-150
20. Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K., Xu K., Strathearn K.E., Liu F., et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313 (2006) 324-328
21. Meggouh F., Bienfait H.M., Weterman M.A., de Visser M., and Baas F. Charcot-Marie-Tooth disease due to a de novo mutation of the RAB7 gene. Neurology 67 (2006) 1476-1478
22. Devon R.S., Orban P.C., Gerrow K., Barbieri M.A., Schwab C., Cao L.P., Helm J.R., Bissada N., Cruz-Aguado R., Davidson T.L., et al. Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. Proc Natl Acad Sci U S A 103 (2006) 9595-9600
23. Hadano S., Benn S.C., Kakuta S., Otomo A., Sudo K., Kunita R., Suzuki-Utsunomiya K., Mizumura H., Shefner J.M., Cox G.A., et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum Mol Genet 15 (2006) 233-250
24. Pal A., Severin F., Lommer B., Shevchenko A., and Zerial M. Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease. J Cell Biol 172 (2006) 605-618
25. Gauthier L.R., Charrin B.C., Borrell-Pages M., Dompierre J.P., Rangone H., Cordelieres F.P., De Mey J., MacDonald M.E., Lessmann V., Humbert S., et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118 (2004) 127-138. This study provided molecular insights into the mechanism of neurodegeneration occurring in HD. Htt was shown to increase BDNF trafficking, while the polyQ form of Htt could not. The deficiency in BDNF transport in cells derived from a mouse line overexpressing mutant Htt was rescued by wild-type Htt. The effect of Htt on transport was mediated by HAP1, which acts as an adaptor for the dynein/dynactin motor complex. This property was not shared by the pathological version of Htt.
26. Rong J., McGuire J.R., Fang Z.H., Sheng G., Shin J.Y., Li S.H., and Li X.J. Regulation of intracellular trafficking of huntingtin-associated protein-1 is critical for TrkA protein levels and neurite outgrowth. J Neurosci 26 (2006) 6019-6030
27. McGuire J.R., Rong J., Li S.H., and Li X.J. Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons. J Biol Chem 281 (2006) 3552-3559
28. Salehi A., Delcroix J.D., Belichenko P.V., Zhan K., Wu C., Valletta J.S., Takimoto-Kimura R., Kleschevnikov A.M., Sambamurti K., Chung P.P., et al. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51 (2006) 29-42. Two mouse strains segmentally trisomic for Chr16 have been used to study the molecular basis of DS: Ts65Dn where an extra copy of the app gene is present together with 140 additional genes; and Ts1Cje that has only 2 copies of app but still bears 100 of the genes present in Ts65Dn. NGF transport was tested by injecting radiolabeled NGF into the hippocampus of control versus diseased mice. Greater impairment of NGF transport was detected in Ts65Dn than in Ts1Cje mice. This was attributed to APP overexpression, since deletion of the extra copy of app in Ts65Dn partially restored transport. This inhibition of NGF transport was observed in mice expressing human APP or mutations in PS1, an APP partner mutated in a familial form of Alzheimer disease (AD). This study provides insights into the AD-like symptoms caused by cholinergic neurodegeneration occurring in elderly DS patients.
29. Gunawardena S., and Goldstein L.S. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32 (2001) 389-401
30. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307 (2005) 1282-1288
31. Lazarov O., Morfini G.A., Pigino G., Gadadhar A., Chen X., Robinson J., Ho H., Brady S.T., and Sisodia S.S. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J Neurosci 27 (2007) 7011-7020
32. Lazarov O., Morfini G.A., Lee E.B., Farah M.H., Szodorai A., DeBoer S.R., Koliatsos V.E., Kins S., Lee V.M., Wong P.C., et al. Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J Neurosci 25 (2005) 2386-2395
33. Muresan Z., and Muresan V. Coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1. J Cell Biol 171 (2005) 615-625
34. Araki Y., Kawano T., Taru H., Saito Y., Wada S., Miyamoto K., Kobayashi H., Ishikawa H.O., Ohsugi Y., Yamamoto T., et al. The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport. EMBO J 26 (2007) 1475-1486
35. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., and Goldstein L.S. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414 (2001) 643-648
36. Cavalli V., Kujala P., Klumperman J., and Goldstein L.S. Sunday Driver links axonal transport to damage signaling. J Cell Biol 168 (2005) 775-787
37. Morfini G., Pigino G., Szebenyi G., You Y., Pollema S., and Brady S.T. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat Neurosci 9 (2006) 907-916
38. Caviston J.P., Ross J.L., Antony S.M., Tokito M., and Holzbaur E.L. Huntingtin facilitates dynein/dynactin-mediated vesicle transport. Proc Natl Acad Sci U S A 104 (2007) 10045-10050
39. Bracale A., Cesca F., Neubrand V.E., Newsome T.P., Way M., and Schiavo G. Kidins220/ARMS is transported by a kinesin-1-based mechanism likely to be involved in neuronal differentiation. Mol Biol Cell 18 (2007) 142-152
40. Liu J.J., Ding J., Wu C., Bhagavatula P., Cui B., Chu S., Mobley W.C., and Yang Y. Retrolinkin, a membrane protein, plays an important role in retrograde axonal transport. Proc Natl Acad Sci U S A 104 (2007) 2223-2228
41. Hollenbeck P.J., and Saxton W.M. The axonal transport of mitochondria. J Cell Sci 118 (2005) 5411-5419
42. De Vos K.J., Chapman A.L., Tennant M.E., Manser C., Tudor E.L., Lau K.F., Brownlees J., Ackerley S., Shaw P.J., McLoughlin D.M., et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum Mol Genet 16 (2007) 2720-2728
43. Miller K.E., and Sheetz M.P. Axonal mitochondrial transport and potential are correlated. J Cell Sci 117 (2004) 2791-2804
44. Santama N., Er C.P., Ong L.L., and Yu H. Distribution and functions of kinectin isoforms. J Cell Sci 117 (2004) 4537-4549
45. Cai Q., Gerwin C., and Sheng Z.H. Syntabulin-mediated anterograde transport of mitochondria along neuronal processes. J Cell Biol 170 (2005) 959-969
46. Glater E.E., Megeath L.J., Stowers R.S., and Schwarz T.L. Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J Cell Biol 173 (2006) 545-557
47. Guo X., Macleod G.T., Wellington A., Hu F., Panchumarthi S., Schoenfield M., Marin L., Charlton M.P., Atwood H.L., and Zinsmaier K.E. The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 47 (2005) 379-393
48. Cox R.T., and Spradling A.C. Milton controls the early acquisition of mitochondria by Drosophila oocytes. Development 133 (2006) 3371-3377
49. Horiuchi D., Barkus R.V., Pilling A.D., Gassman A., and Saxton W.M. APLIP1, a kinesin binding JIP-1/JNK scaffold protein, influences the axonal transport of both vesicles and mitochondria in Drosophila. Curr Biol 15 (2005) 2137-2141
50. Jimenez-Mateos E.M., Gonzalez-Billault C., Dawson H.N., Vitek M.P., and Avila J. Role of MAP1B in axonal retrograde transport of mitochondria. Biochem J 397 (2006) 53-59
51. Wozniak M.J., Melzer M., Dorner C., Haring H.U., and Lammers R. The novel protein KBP regulates mitochondria localization by interaction with a kinesin-like protein. BMC Cell Biol 6 (2005) 35
52. Brooks A.S., Bertoli-Avella A.M., Burzynski G.M., Breedveld G.J., Osinga J., Boven L.G., Hurst J.A., Mancini G.M., Lequin M.H., de Coo R.F., et al. Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems. Am J Hum Genet 77 (2005) 120-126
53. Lyons D.A., Naylor S.G., Mercurio S., Dominguez C., and Talbot W.S. KBP is essential for axonal structure, outgrowth and maintenance in zebrafish, providing insight into the cellular basis of Goldberg-Shprintzen syndrome. Development 135 (2008) 599-608
54. Chada S.R., and Hollenbeck P.J. Nerve growth factor signaling regulates motility and docking of axonal mitochondria. Curr Biol 14 (2004) 1272-1276
55. Baloh R.H., Schmidt R.E., Pestronk A., and Milbrandt J. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J Neurosci 27 (2007) 422-430
56. Detmer S.A., Vande Velde C., Cleveland D.W., and Chan D.C. Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A. Hum Mol Genet 17 (2008) 367-375
57. Rui Y., Tiwari P., Xie Z., and Zheng J.Q. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J Neurosci 26 (2006) 10480-10487
58. Misgeld T., Kerschensteiner M., Bareyre F.M., Burgess R.W., and Lichtman J.W. Imaging axonal transport of mitochondria in vivo. Nat Methods 4 (2007) 559-561. This powerful imaging technique enables to monitor the transport of fluorescently tagged mitochondria in the nervous system in situ or in tissue explants. Anterograde and retrograde transport of mitochondria has been shown to be impaired in transected intercostal nerves. This technique is predicted to be crucial in furthering our understanding of mitochondrial dynamics in healthy and diseased neurons.
59. Piper M., and Holt C. RNA translation in axons. Annu Rev Cell Dev Biol 20 (2004) 505-523
60. Cox L.J., Hengst U., Gurskaya N.G., Lukyanov K.A., and Jaffrey S.R. Intra-axonal translation and retrograde trafficking of CREB promotes neuronal survival. Nat Cell Biol 10 (2008) 149-159. Using compartmentalised cultures, allowing the separation of cell bodies from nerve terminals, the authors showed that CREB mRNA was translated in axons after NGF treatment. This was confirmed by using a GFP reporter under the control of the CREB promoter. The newly translated protein was then retrogradely transported, possibly in signalling endosomes containing TrkA, and participated in the NGF-mediated nuclear response.
61. van Niekerk E.A., Willis D.E., Chang J.H., Reumann K., Heise T., and Twiss J.L. Sumoylation in axons triggers retrograde transport of the RNA-binding protein La. Proc Natl Acad Sci U S A 104 (2007) 12913-12918. The RNA binding protein La was shown to be modified by SUMO in dorsal root ganglia neurons. While kinesin-1 binds La independently of sumoylation, the formation of a La-dynein complex is strictly sumoylation-dependent. Consequently, inhibition of La sumoylation by mutation of the SUMO accepting site led to impairment of its retrograde transport. SUMO could have a more general role in axonal transport since SUMO staining has been found preferentially at the distal side of a ligated sciatic nerve, where retrograde cargoes do accumulate.
62. Martin S., Wilkinson K.A., Nishimune A., and Henley J.M. Emerging extranuclear roles of protein sumoylation in neuronal function and dysfunction. Nat Rev Neurosci 8 (2007) 948-959
63. Steffan J.S., Agrawal N., Pallos J., Rockabrand E., Trotman L.C., Slepko N., Illes K., Lukacsovich T., Zhu Y.Z., Cattaneo E., et al. SUMO modification of Huntingtin and Huntington's disease pathology. Science 304 (2004) 100-104
64. Mizushima N., Levine B., Cuervo A.M., and Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 451 (2008) 1069-1075
65. Ravikumar B., Acevedo-Arozena A., Imarisio S., Berger Z., Vacher C., O'Kane C.J., Brown S.D., and Rubinsztein D.C. Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat Genet 37 (2005) 771-776